Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation

Journal of Clinical Oncology, Vol 10, 1976-1982, Copyright © 1992 by American Society of Clinical Oncology


ARTICLES

Cancer Pain Assessment and Treatment Curriculum Guidelines. The Ad Hoc Committee on Cancer Pain of the American Society of Clinical Oncology


PURPOSE: More than 70% of patients with cancer develop significant pain at some time during the course of their illness. Despite the general consensus that most cancer pain can be treated effectively, many patients receive inadequate treatment of their pain. One significant contributing factor is the failure of health care professionals to receive formal training in this important aspect of oncology. The Cancer Pain Assessment and Treatment Curriculum Guidelines reflect the American Society of Clinical Oncology's commitment to providing optimal pain relief to patients with cancer. These guidelines represent an effort to promote formal instruction on the assessment and treatment of cancer pain in training programs and continuing education courses. DESIGN AND RESULTS: The curriculum is broad in scope and applicable to patients of all ages. The guidelines emphasize the need for (1) routine pain assessment, (2) proficiency in prescribing opioids, nonopioid analgesics, and adjuvant medications, and (3) an understanding of the potential benefits of antineoplastic, anesthetic, neurosurgical, and behavioral approaches, which often require a coordinated multidisciplinary approach. CONCLUSION: This curriculum should prove a valuable guide to those who wish further education on the optimal treatment of cancer pain.


This article has been cited by other articles:


Home page
ChestHome page
P. A. Selecky, C. A. H. Eliasson, R. I. Hall, R. F. Schneider, B. Varkey, ACCP Ethics Committee, and D. R. McCaffree
Palliative and End-of-Life Care for Patients With Cardiopulmonary Diseases: American College of Chest Physicians Position Statement
Chest, November 1, 2005; 128(5): 3599 - 3610.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
L. W. C. Chow, K.-Y. Yuen, P. C. Y. Woo, and W. I. Wei
Clarithromycin Attenuates Mastectomy-Induced Acute Inflammatory Response
Clin. Vaccine Immunol., November 1, 2000; 7(6): 925 - 931.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
A. B. Karnad, H. N. Blansfield, J. H. Kilwein, A. N. Goodman, C. S. Marcus, W. M. O'Neill, E. J. Chambers, M. T. Fallon, W. D. Bloomer, C. S. Cleeland, et al.
Treating Cancer Pain
N. Engl. J. Med., July 21, 1994; 331(3): 199 - 201.
[Full Text]



About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 PDA Services

Copyright © 1992 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online